BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

575 hedge funds and large institutions have $18.9B invested in BioMarin Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 198 increasing their positions, 202 reducing their positions, and 48 closing their positions.

Holders
575
Holders Change
+28
Holders Change %
+5.12%
% of All Funds
9.28%
Holding in Top 10
15
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+15.38%
% of All Funds
0.24%
New
87
Increased
198
Reduced
202
Closed
48
Calls
$185M
Puts
$117M
Net Calls
+$68.2M
Net Calls Change
+$35.2M

Top Buyers

1
Invesco
1
Invesco
Georgia
$190M
2
CG
2
Carmignac Gestion
France
$89.9M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$585M
4
PAMS
4
Pictet Asset Management (Switzerland)
Switzerland
$153M
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$176M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$402M
2
Millennium Management
2
Millennium Management
New York
$81.3M
3
Ameriprise
3
Ameriprise
Minnesota
$481M
4
Citadel Advisors
4
Citadel Advisors
Florida
$13.5M
5
PHS
5
PFM Health Sciences
California
$32.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Primecap Management
1
Primecap Management
California
$1.82B 17,580,859 -44,646 -0.3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.8B 17,365,080 +256,791 +2%
BlackRock
3
BlackRock
New York
$1.5B 14,540,191 +252,332 +2%
Dodge & Cox
4
Dodge & Cox
California
$1.49B 14,383,663 -390,300 -3%
BBA
5
Baker Bros. Advisors
New York
$789M 7,620,494 – –
Capital Research Global Investors
6
Capital Research Global Investors
California
$585M 5,651,001 +714,261 +14%
State Street
7
State Street
Massachusetts
$558M 5,388,844 +110,406 +2%
Viking Global Investors
8
Viking Global Investors
Connecticut
$546M 5,273,620 +174,456 +3%
Ameriprise
9
Ameriprise
Minnesota
$481M 4,648,628 -1,046,606 -18%
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$402M 3,888,444 -4,371,004 -53%
ACA
11
Avoro Capital Advisors
New York
$368M 3,555,555 – –
Norges Bank
12
Norges Bank
Norway
$285M 2,754,017 +157,654 +6%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$267M 2,584,104 +69,581 +3%
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
$265M 2,560,644 +506,252 +25%
Deutsche Bank
15
Deutsche Bank
Germany
$247M 2,388,766 +175,192 +8%
Parnassus Investments
16
Parnassus Investments
California
$242M 2,338,529 -227,551 -9%
Barclays
17
Barclays
United Kingdom
$205M 1,982,489 -270,314 -12%
PAI
18
Palo Alto Investors
California
$195M 1,885,811 -90,454 -5%
Invesco
19
Invesco
Georgia
$190M 1,835,061 +1,430,955 +354%
Amundi
20
Amundi
France
$186M 1,673,693 -70,739 -4%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$176M 1,703,799 +557,851 +49%
O
22
OrbiMed
New York
$167M 1,615,210 -102,100 -6%
PAMS
23
Pictet Asset Management (Switzerland)
Switzerland
$153M 1,478,521 +710,154 +92%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$146M 1,409,124 +389,867 +38%
Northern Trust
25
Northern Trust
Illinois
$135M 1,305,190 +11,683 +0.9%
1
2 3 4 5